Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery

Aim. To assess the clinical value of cystatin C for the prediction of the in-hospital complication risk among patients with coronary heart disease (CHD) who underwent coronary artery bypass graft surgery (CABG). Material and methods. The perioperative period data were analysed for 583 patients who u...

Full description

Saved in:
Bibliographic Details
Main Authors: K. S. Shafranskaya, V. V. Kashtalap, A. A. Kuzmina, O. V. Gruzdeva, A. M. Grigoriev, A. N. Sumin, O. L. Barbarash, L. S. Barbarash
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2013-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/385
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250713072304128
author K. S. Shafranskaya
V. V. Kashtalap
A. A. Kuzmina
O. V. Gruzdeva
A. M. Grigoriev
A. N. Sumin
O. L. Barbarash
L. S. Barbarash
author_facet K. S. Shafranskaya
V. V. Kashtalap
A. A. Kuzmina
O. V. Gruzdeva
A. M. Grigoriev
A. N. Sumin
O. L. Barbarash
L. S. Barbarash
author_sort K. S. Shafranskaya
collection DOAJ
description Aim. To assess the clinical value of cystatin C for the prediction of the in-hospital complication risk among patients with coronary heart disease (CHD) who underwent coronary artery bypass graft surgery (CABG). Material and methods. The perioperative period data were analysed for 583 patients who underwent CABG in March-November 2011. Before the surgery, all patients underwent colour duplex ultrasound of peripheral arteries. One day before CABG and at Day 7 after the surgery, serum levels of creatinine and glomerular filtration rate (GFR; MDRD formula) were assessed. In 150 participants, cystatin C concentration was measured one day before the surgery and at Day 7 after CABG. The incidence of in-hospital adverse outcomes of CABG, such as myocardial infarction, stroke, acute renal failure, and repeat mediastinotomy, was evaluated. In all participants, the risk levels by the EuroSCORE scale were measured. Results. Pre- and post-surgery levels of serum creatinine and GFR did not differ significantly between the low, intermediate, and high EuroSCORE risk groups. Moreover, pre- and post-CABG levels of serum creatinine and GFR were similar in patients with favourable and adverse outcomes. However, the concentration of cystatin C, both before and after CABG, was significantly higher in patients with adverse outcomes, compared to participants with favourable outcomes. Conclusion. These findings suggest that cystatin C could be used as a universal prognostic marker of cardiovascular complications and renal dysfunction in post-CABG patients.
format Article
id doaj-art-c23f0db0821c4cf3af7c25e03f91111d
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2013-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-c23f0db0821c4cf3af7c25e03f91111d2025-08-20T03:57:09Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202013-06-0103455010.15829/1560-4071-2013-3-45-50385Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgeryK. S. Shafranskaya0V. V. Kashtalap1A. A. Kuzmina2O. V. Gruzdeva3A. M. Grigoriev4A. N. Sumin5O. L. Barbarash6L. S. Barbarash7Research Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaResearch Institute of Complex Cardiovascular Problems, Kemerovo, RussiaAim. To assess the clinical value of cystatin C for the prediction of the in-hospital complication risk among patients with coronary heart disease (CHD) who underwent coronary artery bypass graft surgery (CABG). Material and methods. The perioperative period data were analysed for 583 patients who underwent CABG in March-November 2011. Before the surgery, all patients underwent colour duplex ultrasound of peripheral arteries. One day before CABG and at Day 7 after the surgery, serum levels of creatinine and glomerular filtration rate (GFR; MDRD formula) were assessed. In 150 participants, cystatin C concentration was measured one day before the surgery and at Day 7 after CABG. The incidence of in-hospital adverse outcomes of CABG, such as myocardial infarction, stroke, acute renal failure, and repeat mediastinotomy, was evaluated. In all participants, the risk levels by the EuroSCORE scale were measured. Results. Pre- and post-surgery levels of serum creatinine and GFR did not differ significantly between the low, intermediate, and high EuroSCORE risk groups. Moreover, pre- and post-CABG levels of serum creatinine and GFR were similar in patients with favourable and adverse outcomes. However, the concentration of cystatin C, both before and after CABG, was significantly higher in patients with adverse outcomes, compared to participants with favourable outcomes. Conclusion. These findings suggest that cystatin C could be used as a universal prognostic marker of cardiovascular complications and renal dysfunction in post-CABG patients.https://russjcardiol.elpub.ru/jour/article/view/385coronary artery bypass graft surgerycystatin c
spellingShingle K. S. Shafranskaya
V. V. Kashtalap
A. A. Kuzmina
O. V. Gruzdeva
A. M. Grigoriev
A. N. Sumin
O. L. Barbarash
L. S. Barbarash
Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
Российский кардиологический журнал
coronary artery bypass graft surgery
cystatin c
title Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
title_full Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
title_fullStr Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
title_full_unstemmed Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
title_short Cystatine C role in predicting the in-hospital adverse outcomes of coronary artery bypass graft surgery
title_sort cystatine c role in predicting the in hospital adverse outcomes of coronary artery bypass graft surgery
topic coronary artery bypass graft surgery
cystatin c
url https://russjcardiol.elpub.ru/jour/article/view/385
work_keys_str_mv AT ksshafranskaya cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT vvkashtalap cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT aakuzmina cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT ovgruzdeva cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT amgrigoriev cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT ansumin cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT olbarbarash cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery
AT lsbarbarash cystatinecroleinpredictingtheinhospitaladverseoutcomesofcoronaryarterybypassgraftsurgery